Company announcements

Announcement type

All

Price-sensitive

Stock code or name

leave blank for all companies

Headline

leave blank for all announcements

Sector

Market Cap ($m)

Announcement date

View top

announcements

Order By

Ascending

Descending

Reset Filters

Search Results

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Axiron License Agreement Terminated	6 Sep 2017 8:26AM	$0.265	$0.012	fallen by 95.47%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Axiron Patent Appeal Hearing Date	24 Aug 2017 9:48AM	$0.245	$0.012	fallen by 95.10%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Appendix 4G	22 Aug 2017 5:13PM	$0.255	$0.012	fallen by 95.29%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	2017 Full Year Results Presentation	22 Aug 2017 5:03PM	$0.255	$0.012	fallen by 95.29%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Appendix 4E and 2017 Financial Report	22 Aug 2017 5:02PM	$0.255	$0.012	fallen by 95.29%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Investor Conference Call 2017 Annual Results	22 Aug 2017 4:12PM	$0.255	$0.012	fallen by 95.29%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Teva Launches Generic Version of Axiron in United States	21 Aug 2017 10:04AM	$0.265	$0.012	fallen by 95.47%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Axiron Net Sales Quarter to 30 June 2017	26 Jul 2017 8:24AM	$0.290	$0.012	fallen by 95.86%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Acrux Presents At Bioshares Biotech Summit	24 Jul 2017 9:48AM	$0.280	$0.012	fallen by 95.71%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Axiron Generic Launched In The United States	6 Jul 2017 9:44AM	$0.230	$0.012	fallen by 94.78%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Institution of IPR Proceeding Against Key Jublia Patent	2 May 2017 11:14AM	$0.280	$0.012	fallen by 95.71%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Axiron Net Sales Quarter to 31 March 2017	26 Apr 2017 9:07AM	$0.275	$0.012	fallen by 95.64%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	S&P DJ Indices Announces March Quarterly Rebalance	10 Mar 2017 8:19AM	$0.290	$0.012	fallen by 95.86%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Ceasing to be a substantial holder	28 Feb 2017 4:40PM	$0.285	$0.012	fallen by 95.79%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Investor Presentation	17 Feb 2017 4:25PM	$0.305	$0.012	fallen by 96.07%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Appendix 4D and Half Year Report to 31 December 2016	17 Feb 2017 3:59PM	$0.305	$0.012	fallen by 96.07%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Investor Call December 16 HY Results Updated Dial-In Details	14 Feb 2017 10:45AM	$0.300	$0.012	fallen by 96%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Change in substantial holding	3 Feb 2017 5:07PM	$0.310	$0.012	fallen by 96.13%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Change in substantial holding	1 Feb 2017 4:34PM	$0.320	$0.012	fallen by 96.25%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Axiron Net Sales, Quarter to December2016	1 Feb 2017 9:47AM	$0.310	$0.012	fallen by 96.13%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Appendix 3B	30 Jan 2017 10:05AM	$0.320	$0.012	fallen by 96.25%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Half-Year Results Investor Conference Call	25 Jan 2017 3:38PM	$0.315	$0.012	fallen by 96.19%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Change in substantial holding	19 Jan 2017 4:33PM	$0.310	$0.012	fallen by 96.13%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Final Director Interest Notice	8 Dec 2016 3:27PM	$0.305	$0.012	fallen by 96.07%
Acrux Limited (ACR) ORDINARY FULLY PAID	Health Care	$6	Resignation of Director	8 Dec 2016 3:25PM	$0.305	$0.012	fallen by 96.07%

426 - 450 of 685 results

Page 18 of 28

+ Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.